AsiaBiome advances the discovery of microbiome-based therapeutics through a proprietary technology platform.
AsiaBiome is a biotechnology company that advances the discovery of microbiome-based therapeutics. AsiaBiome builds a platform that includes a Microbiota Bank, a clinical intervention platform, and core Big Data technology that powers the bioinformatics pipeline, to accelerate the drug discovery for live bio-therapeutics.AsiaBiome was founded on 2016 and is based in Hong Kong.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 22, 2019 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
500 Global | — | Seed |